This week’s newsletter covers a major CBD product recall, surprising findings about “magic mushroom” edibles, promising preclinical research on CBD ...

This week’s newsletter covers the uncertain fate of cannabis rescheduling under the Trump administration, along with new research on psychedelic ...

This week’s newsletter covers the latest research and journalism on plant medicine, including a landmark study on psilocybin microdosing and ...

This week’s newsletter explores the political roots of psychedelic prohibition, ancient uses of mind-altering substances, new research on how ...

This week’s newsletter covers the limits of cannabis rescheduling on federal criminal penalties, the largely symbolic nature of Trump’s psychedelics ...

This week’s newsletter covers CBD’s potential to reduce Alzheimer’s-related brain inflammation, psilocybin’s promise for pain relief and neurological ...

This week’s newsletter covers CBD’s potential for addressing digital era fatigue, critical perspectives on psychedelic research and clinical ...

This week’s newsletter covers a promising psychedelic therapy pilot study for clinical depression, psilocybin research on dementia and childhood ...